Wikipedia -WSS

Wikipedia

author：explore 2025-09-29 16:45:50 - browse：2614

Exterior photo of UnitedHealth Group building — UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

There’s now a two-party showdown for one of the largest home health companies in the country.

UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Listen: Biogen's potential pivot, & Illumina's next chapter

WSS

The drug industry has found itself all alone in Washington

NEJM study link tiny plastics in blood vessels to heart problems

Humana sues Biden admin over Medicare Advantage audit rule

Just how do doctors, lawmakers, and the public define abortion?

The Readout: Amylyx, Alumis, and Lundbeck drug updates

How generative AI is inspiring dreams of a health data revolution

knowledge

Wikipedia

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Psychedelics group wrestles with new pharma identity

Sen. Paul opposes bill to ban Chinese biotechs

Bright Health sells Medicare Advantage business to Molina

Crinetics acromegaly drug succeeds in late

United colonoscopy coverage change 'may cost lives,' doctors say

NIH nominee Bertagnolli will get October confirmation hearing

In age of alternative facts, a scholarly course on calling out crap

Trump surgeon general acknowledges mistakes during Covid

Wikipedia

The 10 drugs up first for Medicare price negotiation

ALS advocates say criticism of new drugs misses bigger picture

Advances in CAR

ALS advocates say criticism of new drugs misses bigger picture

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Air quality improving but still lags in Black, Hispanic communities

hotspot

focus

hotspot

focus